Evidence map›Paper›PMID 42376891›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Hydrophilic-Stable Nucleoside-Based Hydrogen-Bonded Organic Frameworks (N-HOF) for Therapeutic Bacterial Hybrid Systems.

Zheng Wang, Hongbin Yu, Tian Chen, Xiangxu Mu, Tiannan Liu, Yuxi Zhao, Ding Bai, Xianglong Han, Hang Zhao

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zheng WangState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Hongbin YuDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tian ChenDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xiangxu MuIEIT Systems Company Limited, Beijing, China.
Tiannan LiuState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Yuxi ZhaoState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Ding BaiState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Xianglong HanState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.ORCID https://orcid.org/0000-0001-7650-8204
Hang ZhaoState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.

Funding

CAMS Innovation Fund for Medical Sciences CIFMS2019-I2M-5-004National Key R&D Program of China 2022YFC2402900National Natural Science Foundation of China 82271035National Regional Joint Key Fund project of China U24A20712Sichuan Provincial Department of Science and Technology 2020YFSY0009Sichuan Provincial Department of Science and Technology 2021-YJ-0021
6 · The paper itself

Abstract

Hydrogen-bonded organic frameworks (HOFs) have emerged as promising materials for biomedical applications owing to their metal-free biocompatibility and recyclability. Notably, most HOFs are synthesized and utilized in organic solvents, limiting their biomedical translation. Although water is a biologically compatible alternative, it competes for hydrogen bonding and disrupts interactions between building blocks, making the construction of stable aqueous HOFs challenging. Inspired by the DNA base pairing structure, the first nucleoside-based HOF (N-HOF-1) was developed using a multi-hydrogen bonding strategy. This framework is synthesized entirely in water by simply mixing 2-amino-2'-fluoro-2'-deoxyadenosine (2FA) and cyanuric acid (CA), enabling grade production while maintaining stability under physiological conditions. Microcrystal electron diffraction (MicroED) and single-crystal X-ray diffraction (SCXRD) studies revealed the confinement of M-shaped water clusters within the channels of N-HOF-1, mimicking DNA hydration and preserving the HOF architecture. Notably, the porous and positively charged properties of N-HOF-1 enable interaction with bacteria to form the bacteria-nanoparticle biohybrid systems. Leveraging the intrinsic bioactivity of nucleoside building blocks, this system enhances engineered bacterial colonization in the periodontium, periodontal tissue regeneration, and lymphoma therapy. These findings highlighted the potential of nucleosides as versatile building blocks for hydrophilically stable HOFs, offering new possibilities for their biomedical applications.

Indexed as

Anti-Bacterial AgentsNucleosidesDeoxyadenosinesHydrogen BondingHydrophobic and Hydrophilic InteractionsTriazinesAnti-Bacterial Agentscyanuric acidDeoxyadenosinesNucleosidesTriazinesbiocompatibilitycocrystalhydrogen bondhydrogen‐bonded organic frameworknucleoside

Identifiers

PMID42376891
PMCPMC13432010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.